reference/7817038

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7817038

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	38
issn	1078-0432
issueIdentifier	5
pageRange	1628-38
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	1628
bibliographicCitation	Rosen LS, Brown J, Laxa B, Boulos L, Reiswig L, Henner WD, Lum RT, Schow SR, Maack CA, Keck JG, Mascavage JC, Dombroski JA, Gomez RF, Brown GL. Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies. Clin Cancer Res. 2003 May;9(5):1628–38. PMID: 12738715.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3c61f875ab359c6349957e325768442 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e395a06ec90d9a70a7bab31544d78388 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e28cbefce834df79301a5d5153b320d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a83f651f64b3a9eacc57229661021f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_611e6497de691cdb5bca4b15514b27db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7c430c702e1173c98d288ea0a3dc0f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_747143d7101f9b55169ee4ede296a7fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d24a4817829b59ff5142c428be81d19 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a49cb6629ce941cbd5b0d616a874c836 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01af9f9ec3569b36b275160a871a916c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87b05067a6f6fc9e67de5e7167d8d952 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b81b0e3d6d5523955237d3240cc08a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da26cad417d0e3983c1e4d52e56228f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fbfbc4a75e2b2355e761939e32febd3
date	200305
identifier	https://pubmed.ncbi.nlm.nih.gov/12738715
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies
discusses	http://id.nlm.nih.gov/mesh/M0009388 http://id.nlm.nih.gov/mesh/M0005633 http://id.nlm.nih.gov/mesh/M0279597
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10968 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312108 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7952 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8768

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129192846 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID175426923 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2950

Total number of triples: 46.